Cardiovascular Associates of the Delaware Valley

Sewell, New Jersey 08080

1 studies enrolling now · 9 studies all time

What they study most

Atrial Fibrillation, Bradycardia, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Heart Failure, Low Cardiac Output, Percutaneous Coronary Intervention, Peripheral Endovascular Intervention, Primary Prevention of Sudden Cardiac Arrest, Secondary Prevention of Sudden Cardiac Arrest, Sinus Node Dysfunction, Ventricular Fibrillation

Studies at this site

• Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention — Recruiting now
• LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System. — Running, not enrolling
• Understanding Outcomes With the EMBLEM™ S-ICD in Primary Prevention Patients With Low Ejection Fraction — Completed
• A 12 Month Site Randomized Trial in Adults With Type 2 Diabetes Mellitus and History of Cardiovascular Disease — Completed
• Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology — Completed
• Longitudinal Surveillance Study of the 4-SITE Lead/Header System — Completed
• Safety and Performance Study of the INGEVITY Lead — Completed
• Guiding Evidence Based Therapy Using Biomarker Intensified Treatment — Stopped early
• Evaluation of Multisensor Data in Heart Failure Patients With Implanted Devices — Completed